REPORTS: A jab at jabs
According to VAERS COVID Vaccine Data, 595,620 reports through Aug. 13, 2021:
72,699 Urgent Care
98,761 Office Visits
4,681 Bell’s Palsy
5,882 Heart Attacks
17,226 Permanently Disabled
These reports are from the Vaccine Adverse Events Reporting System.
In 2002-2003, an attempted virus vaccine was pulled off the market after about 150 deaths. Why is this current jab continued? Is it because the medical establishment, hospitals and drug companies want the money?
Is Kootenai Health pressuring medical practitioners NOT to use Ivermectin, Hydroxychloroquine, Budesonide inhalers for early COVID outpatient treatment because they want the money? KH gets big money from the federal government for each COVID patient admitted ($13,000?) and even much more money for each COVID death.
Are the FDA, CDC, NIH and other 3-letter Federal agencies hopelessly corrupted by the drug companies so this experimental vaccine will not be pulled from the market? Early outpatient treatment is not recommended even though very successful. Why?
Is this experimental vaccine safe? Maybe NOT! Effective? NO, vaccinated can GET and GIVE COVID!
I am angry and upset with those that promote massive lies. I no longer trust them.
Editor’s note: The Press asked Kootenai Health to explain how it bills COVID patients. Here’s the response:
Medicare patients only
Beginning around March 2020, the Federal waivers increased DRG reimbursement rates by 20% for any Medicare inpatient admitted with one of the newly established COVID-19 diagnoses (DRG’s). The government made this adjustment in recognition of hospitals’ increased costs incurred for care of COVID-positive patients, (e.g. personal protective equipment, dedicated units, extended lengths of stay) applicable to all hospital facilities across the country. The expectation is that this federal support of increased expense to care for COVID-19 patients will continue until the Federal Government ends the COVID-19 Emergency status.
Commercial and Medicaid patients
This does NOT apply to commercial or Medicaid patients. The hospital bills and is paid at previously established rates, with no additional compensation to accommodate for increased cost of care. Commercial and Medicaid reimbursement is directly connected to the diagnosis, care provided, length of stay and rates contracted with each payer through individual negotiations. These rates are disclosed openly by all U.S. providers through the Price Transparency initiative passed by Congress prior to the COVID-19 emergency.
Uninsured patients with a COVID-19 diagnosis are billed to the federal government through the Health Resources and Services Administration (HRSA), if the patient meets certain federal requirements. This HRSA program will pay hospitals at Medicare rates. At Kootenai Health, we have had very few inpatients included in the program. Almost all of our HRSA billing is for outpatient services. If the patient does not provide the information required, the hospital is able to bill the patient directly. However, based on financial need, the patient can also apply for Financial Assistance or Charity Care.